Sat. Nov 23rd, 2024

By Modupe Gbadeyanka

One of the foremost pharmaceutical companies in Nigeria, GlaxoSmithKline Consumer Nigeria Plc, has adjourned its board meeting.

In a statement issued last week, GlaxoSmithKline, also known as GSK, disclosed that on Wednesday, March 9, 2017, its Board of Directors met, but further adjourned the meeting to Friday, March 17, 2017.

At the next meeting, the company said its board will then consider and approve the 2016 Audited Financial Statements, the amount to be recommended to members as dividend at the next Annual General Meeting (AGM) and fix the date and venue of the AGM.

However, the statement said shareholders would be “informed of the board’s decisions immediately after the meeting.”

It then urged the general public to “take note that the closed period for dealing in the company’s securities by the directors, managers or connected persons commenced on February 10, 2017 and shall now terminate on Thursday, March 23, 2017.”

By Modupe Gbadeyanka

Modupe Gbadeyanka is a fast-rising journalist with Business Post Nigeria. Her passion for journalism is amazing. She is willing to learn more with a view to becoming one of the best pen-pushers in Nigeria. Her role models are the duo of CNN's Richard Quest and Christiane Amanpour.

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *